Telix Pharmaceuticals Limited

TLPPF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$3-$12$12$20
Dep. & Amort.$15-$2$2$4
Deferred Tax$0$0$0$43
Stock-Based Comp.$18$0$0$7
Change in WC$0-$64$0-$58
Other Non-Cash-$2$82$21-$5
Operating Cash Flow$27$9$34$11
Investing Activities
PP&E Inv.-$10-$1-$14-$8
Net Acquisitions-$349-$12-$23-$0
Inv. Purchases$0-$52$0-$13
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$34-$25-$9-$2
Investing Cash Flow-$393-$89-$46-$23
Financing Activities
Debt Repay.-$5$653$2$1
Stock Issued$0-$2$3$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1-$19$2$4
Financing Cash Flow-$4$635$4$5
Forex Effect$17$40$1-$2
Net Chg. in Cash$315$592-$4-$8
Supplemental Information
Beg. Cash$0$119$123$132
End Cash$315$710$119$123
Free Cash Flow$17-$11$20$3
Telix Pharmaceuticals Limited (TLPPF) Financial Statements & Key Stats | AlphaPilot